Rajesh Karki

This inventor holds 16 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 7 EPO patents. Top assignee: Novartis Ag. Active years: 2013-2025.

USPTO Granted Patents = 16 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 7 (Patent Applications = 7)

Average Co-Inventor Count = 11.2

ph-index = 6

Forward Citations = 97(Granted Patents)

Location History:

Cambridge, MA (US) (2013)
Quincy, MA (US) (2017 - 2024)

Company Filing History:

16 out of 3,973

Novartis Ag

patents

Years Active: 2013-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12209098 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 (2025-01-28),

2. 12129246 - Hydroquinazoline derivatives for the treatment of a disease or disorder (2024-10-29),

3. 11952386 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 (2024-04-09),

4. 11905283 - Compounds and compositions for inhibiting the activity of SHP2 (2024-02-20),

5. 11401259 - 1-Pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2 (2022-08-02),

6. 10968235 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 (2021-04-06),

7. 10934285 - Compounds and compositions for inhibiting the activity of SHP2 (2021-03-02),

8. 10774065 - 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2 (2020-09-15),

9. 10377770 - Tricyclic compounds and compositions as kinase inhibitors (2019-08-13),

10. 10336774 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 (2019-07-02),

11. 10301278 - 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2 (2019-05-28),

12. 10287266 - Compounds and compositions for inhibiting the activity of SHP2 (2019-05-14),

13. 10093646 - 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2 (2018-10-09),

14. 10077276 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 (2018-09-18),

15. 9815813 - 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2 (2017-11-14),

Title: The Innovative Journey of Rajesh Karki

Introduction: Rajesh Karki, a talented inventor based in Quincy, MA (US), has made significant contributions to the field of technology with his creative innovations and patented inventions.

Latest Patents: Rajesh Karki holds several patents in various technological domains, including artificial intelligence, renewable energy, and healthcare devices. His most recent patent focuses on a groundbreaking AI algorithm for predictive maintenance in industrial machinery.

Career Highlights: With a background in engineering and a passion for problem-solving, Rajesh Karki has had a successful career marked by innovative breakthroughs. He has worked for leading tech companies, where he has spearheaded projects that have resulted in cutting-edge inventions.

Collaborations: Throughout his career, Rajesh Karki has collaborated with top researchers, engineers, and scientists to bring his ideas to life. His ability to work in multidisciplinary teams has led to the development of revolutionary technologies that have had a lasting impact on various industries.

Conclusion: Rajesh Karki's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His passion for creating solutions to complex problems continues to drive him towards new discoveries and advancements in technology.